The NLRP3 inflammasome has been linked to both protective and pathologic immune responses. Its appropriate activation triggers the innate immune response to invading pathogens including influenza virus, Staphylococcus aureus and Candida albicans; in contrast aberrant activation of the NLRP3 inflammasome is implicated in the pathogenesis of a variety of sterile inflammatory diseases. Activation of the NLRP3 inflammasome is a multistep process that culminates in the activation of the cysteine protease caspase-1, which subsequently results in the processing and secretion of the proinflammatory cytokines IL-1? and IL-18. The precise steps leading to activation of the NLRP3 inflammasome are not well understood but involve mitochondrial dysfunction and cation flux. Importantly we have found that the mitochondrial specific lipid cardiolipin directly binds to NLRP3 and caspase-1 and is required for NLRP3 inflammasome activation. We propose that the mitochondrion serves as an activating platform for the assembly and activation of the NLRP3 inflammasome. We will define how the mitochondrion specifically interacts with NLRP3 inflammasome components during the priming and activation steps in NLRP3 inflammasome. We will determine if calcium flux, the generation of reactive oxygen species, and changes in mitochondrial dynamics trigger the critical interaction between NLRP3 inflammasome components and the mitochondrion. Numerous sterile inflammatory processes are caused by inappropriate activation of the NLRP3 inflammasome. We have previously shown the inflammatory response to acetaminophen-induced hepatotoxicity and pulmonary silicosis is dependent upon activation of the NLRP3 inflammasome. We will use these two clinically relevant models of NLRP3-dependent pathogenic sterile inflammation to identify novel therapeutic targets that can disrupt activation of the NLRP3 inflammasome in vivo.

Public Health Relevance

Aberrant activation of the NLRP3 inflammasome is implicated in the pathogenesis of a number of chronic inflammatory and metabolic diseases. Our ability to inhibit this inflammatory process is limited by a lack of understanding of how the NLRP3 inflammasome is activated. We propose to identify these unknown steps required for NLRP3 inflammasome assembly and activation and thereby identify new therapeutic targets to stop the progression of tissue damage in sterile inflammatory diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI118719-01A1
Application #
9170836
Study Section
Innate Immunity and Inflammation Study Section (III)
Program Officer
Palker, Thomas J
Project Start
2016-08-01
Project End
2021-07-31
Budget Start
2016-08-01
Budget End
2017-07-31
Support Year
1
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Cedars-Sinai Medical Center
Department
Type
DUNS #
075307785
City
Los Angeles
State
CA
Country
United States
Zip Code
90048
Elliott, Eric I; Miller, Alexis N; Banoth, Balaji et al. (2018) Cutting Edge: Mitochondrial Assembly of the NLRP3 Inflammasome Complex Is Initiated at Priming. J Immunol 200:3047-3052
Vrentas, Catherine E; Schaut, Robert G; Boggiatto, Paola M et al. (2018) Inflammasomes in livestock and wildlife: Insights into the intersection of pathogens and natural host species. Vet Immunol Immunopathol 201:49-56
Hornick, Emma E; Banoth, Balaji; Miller, Ann M et al. (2018) Nlrp12 Mediates Adverse Neutrophil Recruitment during Influenza Virus Infection. J Immunol 200:1188-1197
Banoth, Balaji; Sutterwala, Fayyaz S (2017) Confounding role of tumor necrosis factor in cryopyrin-associated periodic syndromes. J Clin Invest 127:4235-4237
Zielinski, Mark R; Gerashchenko, Dmitry; Karpova, Svetlana A et al. (2017) The NLRP3 inflammasome modulates sleep and NREM sleep delta power induced by spontaneous wakefulness, sleep deprivation and lipopolysaccharide. Brain Behav Immun 62:137-150
Vijay, Rahul; Fehr, Anthony R; Janowski, Ann M et al. (2017) Virus-induced inflammasome activation is suppressed by prostaglandin D2/DP1 signaling. Proc Natl Acad Sci U S A 114:E5444-E5453
Clay, Gwendolyn M; Valadares, Diogo G; Graff, Joel W et al. (2017) An Anti-Inflammatory Role for NLRP10 in Murine Cutaneous Leishmaniasis. J Immunol 199:2823-2833
Sebag, Sara C; Koval, Olha M; Paschke, John D et al. (2017) Mitochondrial CaMKII inhibition in airway epithelium protects against allergic asthma. JCI Insight 2:e88297
Janowski, Ann M; Colegio, Oscar R; Hornick, Emma E et al. (2016) NLRC4 suppresses melanoma tumor progression independently of inflammasome activation. J Clin Invest 126:3917-3928
Ulland, Tyler K; Jain, Nidhi; Hornick, Emma E et al. (2016) Nlrp12 mutation causes C57BL/6J strain-specific defect in neutrophil recruitment. Nat Commun 7:13180